Aquestive Therapeutics, Inc. (AQST)

Aquestive Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	60.54	71.55	23.87	27.27	28.02	31.81
Cash & Short-Term Investments	60.54	71.55	23.87	27.27	28.02	31.81
Cash Growth	-32.64%	199.71%	-12.47%	-2.68%	-11.89%	-35.52%
Accounts Receivable	11.86	7.34	8.47	4.7	12.12	6.96
Inventory	8.13	6.04	6.77	5.78	4.04	2.46
Other Current Assets	1.2	3.29	1.85	2.13	3.08	3.4
Total Current Assets	81.72	88.22	40.97	39.89	47.26	44.63
Net Property, Plant & Equipment	8.77	8.98	9.74	9.3	7.78	10.32
Other Intangible Assets	-	-	1.28	1.44	0.05	0.1
Other Long-Term Assets	3.21	4.22	5.44	6.45	6.9	7.84
Total Assets	93.7	101.42	57.42	57.07	61.99	62.88
Accounts Payable	11.95	10.29	8.93	9.95	8.31	7.09
Accrued Expenses	5	5.91	6.5	7.97	8.74	8.57
Short-Term Debt	3.18	0.03	0.02	18.7	2.03	2.58
Current Portion of Leases	0.57	0.51	0.39	0.26	0.9	0.73
Unearned Revenue	1.09	1.05	1.55	1.51	0.77	0.69
Other Current Liabilities	1.36	1.09	0.92	1.15	1.23	1.45
Total Current Liabilities	23.16	18.87	18.31	39.53	21.96	21.1
Long-Term Debt	31.84	32.5	27.51	33.45	51.55	34.33
Long-Term Leases	4.67	4.97	5.4	5.09	1.95	2.85
Other Long-Term Liabilities	106.62	105.25	112.69	97.56	68.67	53.1
Total Long-Term Liabilities	143.13	142.72	145.6	136.1	122.16	90.28
Total Liabilities	166.29	161.58	163.91	175.62	144.13	111.38
Common Stock	0.1	0.09	0.07	0.06	0.04	0.04
Additional Paid-in Capital	327	302.97	212.52	192.6	174.62	137.73
Retained Earnings	-399.69	-363.21	-319.08	-311.21	-256.8	-186.26
Shareholders' Equity	-72.59	-60.16	-106.49	-118.55	-82.13	-48.5
Total Liabilities & Equity	93.7	101.42	57.42	57.07	61.99	62.88
Total Debt	40.26	38	33.32	57.49	56.42	40.48
Net Cash (Debt)	20.28	33.54	-9.45	-30.22	-28.4	-8.67
Net Cash Growth	-39.54%	-	-	-	-	-
Net Cash Per Share	0.21	0.39	-0.15	-0.62	-0.75	-0.26
Book Value	-72.59	-60.16	-106.49	-118.55	-82.13	-48.5
Book Value Per Share	-0.77	-0.69	-1.74	-2.43	-2.16	-1.44
Tangible Book Value	-72.59	-60.16	-107.77	-119.99	-82.19	-48.6
Tangible Book Value Per Share	-0.77	-0.69	-1.76	-2.46	-2.16	-1.44

Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q